Benzinga··Vandana SinghHims & Hers Settles Novo Nordisk Patent Dispute, Inks GLP-1 Partnership
Hims & Hers and Novo Nordisk end legal battle, partnering to distribute weight-loss drugs via telehealth. Stock surges 48.67% despite mixed guidance.
NVOHIMSguidance missearnings beat